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Introduction. Varenicline is a selective α4β2 nicotinic receptor 
partial agonist used as an aid for smoking cessation (Champix
®
, 
Chantix
®
). Adverse effects are generally mild and self-limiting, 
with gastro-intestinal effects most commonly reported. Varenicline 
use has also been associated with psychiatric troubles and adverse 
effect reporting has resulted in warnings of a possibly increased 
risk of suicide. Here, we describe the first fatality associated with 
an intentional suicidal ingestion of a varenicline overdose, 
resulting in extremely high blood concentrations. Case Report. On 
a cold morning, a man was found dead, lying almost naked at the 
side of the street. The direct vicinity of the body suggested that he 
had been rooting up the sandy earth and leaves. His car, parked a 
bit further, contained his clothes, as well as a farewell note and six 
empty blisters of Champix
®
 1 mg. Peripheral blood, urine and 
vitreous were sampled on site for routine toxicological analysis. 
The results indicated that, apart from ethanol and caffeine, 
varenicline was the only drug present. Methods. Quantitative 
determination of varenicline encompassed an optimized solid 
phase extraction, derivatization and analysis by GC-MS. Linearity 
of the established calibration line was evaluated, as were precision 
and accuracy at the lower (1.56 ng/ml) and upper (50 ng/ml) limit 
of quantification and at low (3 ng/ml) and high (30 ng/ml) QC 
levels. In addition, we evaluated the validity of the approach for 
haemolysed blood and urine and for samples with ultrahigh 
concentrations that were diluted in blank serum. Results. 
Acceptable precision (<15% RSD) and accuracy (100% ± 15% of 
the nominal concentration) were obtained at LLOQ, ULOQ and 
both QC levels. Also the analysis of matrices other than serum -
using the approach of standard addition- and of diluted highly 
concentrated samples resulted in acceptable precision and accuracy. 
The blood (vena subclavia resp. vena femoralis), urine and 
vitreous of the deceased had varenicline concentrations of 262, 257, 
687 and 165 ng/ml, respectively. Conclusion. The blood 
concentration of more than 250 ng/ml is almost 10-fold higher than 
the highest concentration described in plasma (28.3 ng/ml) so far. 
Although, with respect to the mechanism of death in this case, 
confounding factors were concomitant ethanol consumption and, 
importantly, potentially fatal hypothermia, this is the first report of 
a fatality associated with the ingestion of an overdose of 
varenicline. 
